Evidence map›Paper›PMID 41785503›Full record

ArticleDrug testing and analysis2026

Evaluating Transcriptomic Biomarkers for rHuEPO Detection: Assessing the Impact of Exercise and Altitude Exposure.

Daria Obratov, Shaun Sutehall, Longhua Liu, Zhao Zhongying, Yannis Pitsiladis

Abstract read
In one paragraph

Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daria ObratovDepartment of Sports and Health Sciences, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.ORCID https://orcid.org/0009-0007-9495-0136
Shaun SutehallResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.ORCID https://orcid.org/0000-0003-3363-7975
Longhua LiuSchool of Exercise and Health, Shanghai University of Sport, Shanghai, China.ORCID https://orcid.org/0000-0001-6501-863X
Zhao ZhongyingCentre for Exercise Science and Medicine (CESAME), Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0003-2743-9008
Yannis PitsiladisCentre for Exercise Science and Medicine (CESAME), Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.ORCID https://orcid.org/0000-0001-6210-2449

Funding

World Anti-Doping Agency (WADA) ISF15E10YP
6 · The paper itself

Abstract

Recombinant human erythropoietin (rHuEPO) is often misused in endurance sports due to its potent erythropoietic effects. While transcriptomic biomarkers hold promise for detecting rHuEPO use beyond conventional testing windows, many proposed gene markers may also respond to physiological stimuli such as exercise or altitude. This study compared 153 previously reported rHuEPO-responsive genes in whole blood with transcripts identified during exercise (GEPREP database) and high-altitude exposure (four independent studies). For the exercise dataset, gene-level statistical outputs were obtained directly from the GEPREP database, while biological relevance was calculated using Cohen's d. Analyses of altitude and rHuEPO datasets followed the original statistical procedures described in each study. Among the 153 rHuEPO-responsive genes, 94 overlapped with altitude and 34 with exercise. However, 50 genes remained unaffected by either exercise or altitude stimuli. Enriched in post-translational regulation and intracellular transport pathways, these genes represent promising candidate transcriptomic markers of rHuEPO administration. This work provides a refined gene panel that reduces the likelihood of false positives and requires further experimental validation before integration into RNA-based detection tests.

Indexed as

AltitudeErythropoietinExerciseSubstance Abuse DetectionTranscriptomeBiomarkersDoping in SportsGene Expression ProfilingHumansRecombinant ProteinsBiomarkersErythropoietinRecombinant Proteinsaltitudeantidopingerythropoietinexercisetranscriptomics

Identifiers

PMID41785503
PMCPMC13040416

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.